Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (2): 140-144.doi: 10.3969/j.issn.1000-6621.2018.02.005
• Expert Note • Previous Articles Next Articles
Received:
2017-11-27
Online:
2018-02-10
Published:
2018-03-14
Rui-hua JIANG,He-ping. XIAO. The thinking of chemotherapy for patients with spinal tuberculosis[J]. Chinese Journal of Antituberculosis, 2018, 40(2): 140-144. doi: 10.3969/j.issn.1000-6621.2018.02.005
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.02.005
[1] |
Mak KC, Cheung KM , Surgical treatment of acute TB spondylitis: indications and outcomes. Eur Spine J 2013,22 Suppl 4: 603-611.
doi: 10.1007/s00586-012-2529-z URL pmid: 22895736 |
[2] | 张光铂 . 脊柱结核诊断中的几个问题. 中国脊柱脊髓杂志, 2003,13(11):645-647. |
[3] |
王传庆, 李敬朝, 侯代伦 , 等. 一期后路Wiltse间隙内固定联合前路病灶清除植骨融合治疗胸腰椎结核的临床疗效评价. 中国防痨杂志, 2014,36(8):659-665.
doi: 10.3969/j.issn.1000-6621.2014.08.012 URL |
[4] |
王高举, 王清, 兰永树 , 等. CT引导下经皮穿刺活检在脊柱占位性病变诊断中的应用. 中国微创外科杂志, 2012,12(1):57-60.
doi: 10.3969/j.issn.1009-6604.2012.01.020 URL |
[5] |
李力韬, 李洪敏, 马远征 , 等. 应用Xpert MTB/RIF对脊柱结核临床标本行结核分枝杆菌与利福平耐药性检测的验证性研究. 中华骨科杂志, 2014,34(2):211-215.
doi: 10.3760/cma.j.issn.0253-2352.2014.02.018 URL |
[6] |
Nene A, Bhojraj S . Results of nonsurgical treatment of thoracic spinal tuberculosis in adults. Spine J, 2005,5(1):79-84.
doi: 10.1016/j.spinee.2004.05.255 URL pmid: 15653088 |
[7] |
Kotil K, Alan MS, Bilge T . Medical management of Pott di-sease in the thoracic and lunbar spine: a prospective clinical study. J Neurosurg Spine, 2007,6(3):222-228.
doi: 10.3171/spi.2007.6.3.222 URL |
[8] |
郝蓉美, 王传庆, 侯代伦 , 等. 脊柱结核非手术治疗临床管理路径研究(附102例临床分析). 中国防痨杂志, 2017,39(8):862-869.
doi: 10.3969/j.issn.1000-6621.2017.08.015 URL |
[9] |
薛海滨, 张聪, 顾苏熙 , 等. 保守方法治疗脊柱结核的适应证和疗效分析. 中国防痨杂志, 2014,36(8):684-690.
doi: 10.3969/j.issn.1000-6621.2014.08.017 URL |
[10] | 中华人民共和国卫生部疾病预防控制局, 中华人民共和国卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南(2008年版).北京: 中国协和医科大学出版社, 2009: 56-57. |
[11] | 王知军 . 骨关节结核的药物治疗新进展. 中国煤炭工业医学杂志, 2012,15(3):463-465. |
[12] | World Health Organization. 耐药结核病规划管理指南(2008年紧急修订版). 中国疾病预防控制中心结核病防治临床中心,世界卫生组织结核病研究培训合作中心,中华医学会结核病学分会,译. 北京:中国疾病预防控制中心结核病防治临床中心,世界卫生组织结核病研究培训合作中心, 中华医学会结核病学分会, 2008: 73-96. |
[13] |
中国防痨协会. 耐药结核病化学治疗指南(2015). 中国防痨杂志, 2015,37(5):421-469.
doi: 10.3969/j.issn.1000-6621.2015.05.001 URL |
[14] |
刘一典, 肖和平 . WHO《耐药结核病治疗指南(2016年更新版)》的特点与思考. 中国防痨杂志, 2016,38(12):1016-1020.
doi: 10.3969/j.issn.1000-6621.2016.12.002 URL |
[15] | 孙雯雯, 吴福蓉, 肖和平 , 等. 强化期含左氧氟沙星方案保守治疗脊柱结核的近期疗效分析. 中国防痨杂志, 2013,35(10):840-842. |
[16] |
姚黎明, 赵茜, 刘丰胜 , 等. 复治脊柱结核的治疗方案及疗效的临床研究. 河北医科大学学报, 2016,37(5):550-554.
doi: 10.3969/j.issn.1007-3205.2016.05.014 URL |
[17] | 郭培宇, 李佩明, 张春强 , 等. 改良标准化疗方案治疗脊柱结核的疗效分析. 昆明医科大学学报, 2015,36(2):54-57. |
[18] | 张正冬, 张海燕, 林存智 . WHO第四版结核病治疗指南解读. 中华临床医师杂志(电子版), 2014,8(23):4251-4253. |
[19] |
Wang Z, Ge Z, Jin W , et al. Treatment of spinal tuberculosis with ultrashort-course chemotherapy in conjunction with partial excision of pathologic vertebrae. Spine J, 2007,7(6):671-681.
doi: 10.1016/j.spinee.2006.07.016 URL |
[20] |
Wang Z, Shi J, Geng G , et al. Ultra-short-course chemo-therapy for spinal tuberculosis: five years of observation. Eur Spine J, 2013,22(2):274-281.
doi: 10.1007/s00586-012-2536-0 URL pmid: 23053764 |
[21] | 秦世炳, 宋言峥, 董伟杰 . 骨关节结核临床诊断与治疗进展及其规范化专题研讨会纪要. 中国防痨杂志, 2013,35(1):81-84. |
[22] |
李建华, 陈非凡, 罗飞 , 等. 49例耐药脊柱结核的耐药表型及个体化治疗的回顾性分析. 中华骨科杂志, 2016,36(11):699-708.
doi: 10.3760/cma.j.issn.0253-2352.2016.11.007 URL |
[23] |
刘丰胜, 姚黎明, 贾晨光 , 等. 病灶持续冲洗在脊柱结核并发脓肿手术治疗中的应用价值. 河北医科大学学报, 2017,38(4):408-411,418.
doi: 10.3969/j.issn.1007-3205.2017.04.009 URL |
[24] |
崔旭, 马远征, 李大伟 , 等. β-磷酸三钙/聚乳酸-聚羟基乙酸/异烟肼/左氧氟沙星缓释材料的成骨检测. 中国组织工程研究, 2013,17(3):381-386.
doi: 10.3969/j.issn.2095-4344.2013.03.001 URL |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||